Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
about
Protein corona - from molecular adsorption to physiological complexityEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsSafety of Nanoparticles in MedicineQuantitative analysis of nanoparticle transport through in vitro blood-brain barrier modelsAnalytical strategies for detecting nanoparticle-protein interactions.The nano-plasma interface: Implications of the protein corona.Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat.Human plasma protein adsorption onto dextranized surfaces: a two-dimensional electrophoresis and mass spectrometry studyDelivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.BSA modification to reduce CTAB induced nonspecificity and cytotoxicity of aptamer-conjugated gold nanorods.Polymeric nanoparticles for the drug delivery to the central nervous system.Interaction of gold nanoparticles with proteins and cells.Shrinkage of pegylated and non-pegylated liposomes in serumInfluence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.Nano carriers for drug transport across the blood-brain barrier.Biocompatibility and nanostructured materials: applications in nanomedicine.Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.Serum-derived nanoparticles: de novo generation and growth in vitro, and internalization by mammalian cells in culture.Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition.Cysteine-capped gold nanoparticles suppress aggregation of proteins exposed to heat stress.Current Application of Capillary Electrophoresis in Nanomaterial Characterisation and Its Potential to Characterise the Protein and Small Molecule Corona.Component-Specific Analysis of Plasma Protein Corona Formation on Gold Nanoparticles Using Multiplexed Surface Plasmon Resonance.Preparation and characterization of PEG-modified PCL nanoparticles for oxygen carrier: a new application of Fourier transform infrared spectroscopy for quantitative analysis of the hemoglobin in nanoparticles.Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriersTrophic transfer of metal-based nanoparticles in aquatic environments: a review and recommendations for future research focusMultifunctional Silica Nanoparticles for Covalent Immobilization of Highly Sensitive Proteins
P2860
Q26853351-CF61F418-05ED-4428-A9AC-A748A12ECC9BQ26996159-0B370C11-D39D-44EA-92BE-7881AF34C666Q28083076-A3D07EAE-33CF-4EF7-AB32-3EEEA0FFB4FAQ28392542-DDB58730-2F0E-450F-B464-1874855B4C72Q33587673-B5CAF257-E5A6-4FB5-A92C-BF9D62442B7DQ34122883-47A636B1-1BD0-4896-9C71-B99C4C339145Q34502573-804641BA-DB68-44C6-8A06-668E3754C3ABQ34704754-87043715-B5CB-43C9-A32C-0F2F693F724EQ34814059-A5498D51-F876-436F-B127-DF1C55553786Q36791673-E1810EDF-6A43-449F-B82A-90FA37724534Q36933043-3B2B7894-35E3-4603-8FB3-9F42F891CBF8Q36992279-26927963-E7E1-4333-AEDC-BEBA90C59DDFQ37076360-6CCDA7FE-287A-459E-84E4-F5A6F9EBDB53Q37400041-A404838F-ADB2-4104-9D9C-C720B64FCDF3Q37449547-026D786F-25FB-436E-B6F5-443D29E508F9Q37588032-CAC8F7E2-0249-405E-9E03-E460DB4996D1Q37668360-49962350-AA57-4CE6-8B84-8AD13AF8AA30Q37835287-B1B10CA7-225E-4E03-85CE-FBDB4B159562Q38820474-95009A08-D17F-4A0A-AEE3-03F0D0DA1E99Q38849743-61CC6803-1D10-408B-AD47-AC19F7B9C800Q38865701-E7A90D24-33F4-420F-8A1B-750A703A11B0Q39555766-51DB2BE7-B75F-42AB-AE3D-126A76E164F0Q42271492-EA2C1D7F-26F8-4EA5-AF22-8CCFD58EA0E1Q42554056-22C397EF-D095-478D-AAC0-260541796AA1Q45127857-D71A370B-04C9-47F7-B076-D7F9DADBB500Q50034205-9D300D2F-53AE-406F-BFE7-D3159BFA6ABBQ51690443-6AD78EAB-5FBB-42B9-9519-D8ECE2A3DAD6Q53600537-2D171D24-A8B2-4EAF-BFC1-1F24490F6850Q57947040-11B8E76A-6474-4EE3-85C8-10E88180339BQ58046142-1F501EB3-D5E9-4F42-A242-430FF9046645Q58812768-019B0E54-B88E-4D8A-B0A7-6B52B627CA3C
P2860
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@ast
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@en
type
label
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@ast
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@en
prefLabel
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@ast
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@en
P2093
P50
P356
P1433
P1476
Analysis of plasma protein ads ...... nd Protein Lab-on-chip system.
@en
P2093
Claudine Delomenie
Dominique Georgin
Fréderic Taran
Hyun Ryoung Kim
Héléne Chacun
Martine Appel
P304
P356
10.1002/ELPS.200600694
P577
2007-07-01T00:00:00Z